Get the Stockscreener App
1.35
4.65%
0.06
After Hours:
1.35
Evogene Ltd Stock (EVGN) Forecast
The Evogene Ltd (EVGN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.4378, representing a -67.57% decrease from the current price of $1.35. The highest analyst price target is $0.6524, and the lowest is $0.2232.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVGN Price Target
Average 2.1868
(+61.98% Upside)
Is Evogene Ltd (EVGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.42 | Neutral |
| STOCH(9,6) | 22.92 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.1688 | Buy |
| ADX(14) | 22.98 | Neutral |
| William %R | -64.29 | Neutral |
| CCI(14) | -13.43 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3535
Sell
|
1.3556
Sell
|
| MA20 |
1.4596
Sell
|
1.4677
Sell
|
| MA50 |
1.8732
Sell
|
1.9011
Sell
|
| MA100 |
2.611
Sell
|
2.7584
Sell
|
| MA200 |
4.7588
Sell
|
4.0285
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EVGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on EVGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.42 indicates that EVGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 22.92 indicates that EVGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EVGN is oversold. This suggests that EVGN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.98 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.43 indicates that EVGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EVGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evogene Ltd financial reports and earnings history, Evogene Ltd (EVGN) stock could reach $0.7023 by 2030, $1.1277 by 2040 and $2.3419 by 2050. See the projected annual prices until 2050 of the Evogene Ltd stock below:
- Evogene Ltd (EVGN) is expected to reach an average price of $0.4118 in 2035, with a high prediction of $0.5098 and a low estimate of $0.4294. This indicates an $-69.50% rise from the last recorded price of $1.35.
- Evogene Ltd (EVGN) stock is projected to chart a bullish course in 2040, with an average price target of $1.1517, representing an $-14.69% surge from its current level. The forecast ranges from a conservative $1.1584 to a sky-high $1.1277.
- Our analysts predict Evogene Ltd (EVGN) to jump 39.40% by 2045, soaring from $1.7197 to an average price of $1.8819, potentially reaching $1.802. While $1.7197 is the low estimate, the potential upside is significant.
- Evogene Ltd (EVGN) stock is expected to climb by 2050, reaching an average of $2.4188, a $79.17% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.3419 and $2.5203, respectively, highlighting the market's uncertainty.
Evogene Ltd Stock (EVGN) Year by Year Forecast
Evogene Ltd Stock (EVGN) Price Forecast for 2025
Evogene Ltd Stock (EVGN) is expected to reach an average price of $2.1868 in 2025, with a high prediction of $4.3718 and a low estimate of $0.00176. This indicates an +61.98% rise from the last recorded price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.5724 | $0.2232 | $0.6524 | -57.60% |
| February, 2025 | $0.5626 | $0.5117 | $0.8047 | -58.33% |
| March, 2025 | $0.3209 | $0.3208 | $0.5586 | -76.23% |
| April, 2025 | $0.2025 | $0.0625 | $0.3931 | -85.00% |
| May, 2025 | $0.1217 | $0.00331 | $0.1317 | -90.98% |
| June, 2025 | $0.041 | $0.011 | $0.2486 | -96.97% |
| July, 2025 | $0.0335 | $0.0175 | $0.5079 | -97.52% |
| August, 2025 | $0.0418 | $0.00176 | $0.4748 | -96.91% |
| September, 2025 | $0.267 | $0.0141 | $0.286 | -80.22% |
| October, 2025 | $1.5726 | $0.1533 | $2.0126 | +16.49% |
| November, 2025 | $3.0318 | $1.1449 | $4.3718 | +124.58% |
| December, 2025 | $1.8034 | $1.6834 | $3.4564 | +33.58% |
Evogene Ltd Stock (EVGN) Price Forecast for 2026
The predicted value for Evogene Ltd (EVGN) in 2026 is set at an average of $5.4141. Estimates vary from a peak of $9.3589 to a trough of $1.4692, indicating an +301.04% surge from the present price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0526 | $1.4692 | $2.4425 | +52.04% |
| February, 2026 | $2.9518 | $2.0449 | $3.8395 | +118.66% |
| March, 2026 | $5.1911 | $2.7642 | $6.0511 | +284.53% |
| April, 2026 | $7.5426 | $4.6334 | $9.3589 | +458.71% |
| May, 2026 | $4.6119 | $2.9373 | $7.375 | +241.62% |
| June, 2026 | $3.7911 | $3.2965 | $4.7842 | +180.82% |
| July, 2026 | $2.6327 | $2.2727 | $4.0934 | +95.01% |
| August, 2026 | $2.7919 | $2.4273 | $3.2619 | +106.81% |
| September, 2026 | $2.3935 | $2.0635 | $3.0131 | +77.30% |
| October, 2026 | $1.9027 | $1.8627 | $2.3958 | +40.94% |
| November, 2026 | $2.192 | $1.6274 | $2.522 | +62.37% |
| December, 2026 | $1.8335 | $1.7135 | $2.7743 | +35.82% |
Evogene Ltd Stock (EVGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evogene Ltd (EVGN) is $1.0752, with a high forecast of $2.1428 and a low forecast of $0.00754. This indicates an -20.36% decrease from the last price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8928 | $1.6582 | $2.1428 | +40.21% |
| February, 2027 | $1.352 | $1.262 | $2.0974 | +0.15% |
| March, 2027 | $1.1636 | $0.9436 | $1.3666 | -13.81% |
| April, 2027 | $0.8128 | $0.6928 | $1.1405 | -39.79% |
| May, 2027 | $0.5721 | $0.3974 | $0.8251 | -57.62% |
| June, 2027 | $0.4436 | $0.269 | $0.7444 | -67.14% |
| July, 2027 | $0.5729 | $0.3782 | $0.8859 | -57.57% |
| August, 2027 | $0.4321 | $0.3621 | $0.6474 | -67.99% |
| September, 2027 | $0.1936 | $0.099 | $0.4044 | -85.66% |
| October, 2027 | $0.0922 | $0.024 | $0.2906 | -93.17% |
| November, 2027 | $0.0543 | $0.00754 | $0.1552 | -95.98% |
| December, 2027 | $0.4537 | $0.0564 | $0.5068 | -66.39% |
Evogene Ltd Stock (EVGN) Price Forecast for 2028
In 2028, Evogene Ltd (EVGN) is projected to reach an average price of $0.3656, with a high projection of $0.7289 and a low estimate of $0.00234. This indicates an -72.92% fall from the last price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.353 | $0.3086 | $0.626 | -73.85% |
| February, 2028 | $0.1722 | $0.0622 | $0.4353 | -87.24% |
| March, 2028 | $0.0838 | $0.00364 | $0.1914 | -93.80% |
| April, 2028 | $0.0449 | $0.00301 | $0.1369 | -96.67% |
| May, 2028 | $0.1333 | $0.0122 | $0.2126 | -90.13% |
| June, 2028 | $0.2102 | $0.012 | $0.3314 | -84.43% |
| July, 2028 | $0.2437 | $0.1255 | $0.3131 | -81.95% |
| August, 2028 | $0.0746 | $0.0746 | $0.2852 | -94.47% |
| September, 2028 | $0.0239 | $0.00836 | $0.1669 | -98.23% |
| October, 2028 | $0.00309 | $0.0115 | $0.0685 | -99.77% |
| November, 2028 | $0.0347 | $0.00234 | $0.1134 | -97.43% |
| December, 2028 | $0.5139 | $0.00804 | $0.7289 | -61.93% |
Evogene Ltd Stock (EVGN) Price Forecast for 2029
The 2029 price forecast for Evogene Ltd Stock (EVGN) is $0.448 on average, with a high prediction of $0.8885 and a low estimate of $0.00747. This represents an -66.82% decrease from the previous price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5255 | $0.4662 | $0.8885 | -61.08% |
| February, 2029 | $0.1808 | $0.0725 | $0.5478 | -86.61% |
| March, 2029 | $0.1449 | $0.1405 | $0.2506 | -89.26% |
| April, 2029 | $0.0487 | $0.00747 | $0.2672 | -96.39% |
| May, 2029 | $0.0599 | $0.0275 | $0.1346 | -95.56% |
| June, 2029 | $0.195 | $0.052 | $0.222 | -85.56% |
| July, 2029 | $0.3532 | $0.1561 | $0.4709 | -73.83% |
| August, 2029 | $0.2874 | $0.2175 | $0.5255 | -78.71% |
| September, 2029 | $0.4215 | $0.2402 | $0.4816 | -68.78% |
| October, 2029 | $0.3386 | $0.3034 | $0.581 | -74.92% |
| November, 2029 | $0.1668 | $0.1668 | $0.4136 | -87.64% |
| December, 2029 | $0.3998 | $0.1741 | $0.3308 | -70.39% |
Evogene Ltd Stock (EVGN) Price Forecast for 2030
Evogene Ltd Stock (EVGN) is expected to reach an average price of $0.7178 in 2030, with a high forecast of $1.0743 and a low forecast of $0.3613. This signifies an -46.83% decrease from the last price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7077 | $0.5561 | $0.7023 | -47.58% |
| February, 2030 | $0.6792 | $0.6738 | $0.6731 | -49.69% |
| March, 2030 | $0.7207 | $0.7046 | $0.7007 | -46.61% |
| April, 2030 | $0.5522 | $0.5817 | $0.5461 | -59.09% |
| May, 2030 | $0.5391 | $0.5237 | $0.5391 | -60.07% |
| June, 2030 | $0.5206 | $0.5152 | $0.4628 | -61.44% |
| July, 2030 | $0.6092 | $0.5414 | $0.5775 | -54.87% |
| August, 2030 | $0.699 | $0.7229 | $0.7283 | -48.22% |
| September, 2030 | $0.238 | $0.4552 | $0.5298 | -82.37% |
| October, 2030 | $0.5674 | $0.3613 | $0.5074 | -57.97% |
| November, 2030 | $1.154 | $0.5628 | $0.9889 | -14.52% |
| December, 2030 | $1.0452 | $0.9351 | $1.0743 | -22.57% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):